Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dechra Pharmaceuticals plc

14 Sep 2023 09:29

RNS Number : 4613M
Societe Generale SA
14 September 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor, and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13/09/2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7,321,056

6.43

24,125

0.02

(2) Cash-settled derivatives:

 

0

0.00

4,693,940

4.12

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

7,321,056

6.43

4,718,065

4.14

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GBP

1p ordinary

Purchase

92,000

38.10952

1p ordinary

Purchase

43

38.1

1p ordinary

Purchase

54

38.1

1p ordinary

Purchase

96

38.1

1p ordinary

Purchase

98

38.1

1p ordinary

Purchase

100

38.1

1p ordinary

Purchase

102

38.1

1p ordinary

Purchase

140

38.12

1p ordinary

Purchase

155

38.1

1p ordinary

Purchase

200

38.1

1p ordinary

Purchase

1

38.12

1p ordinary

Purchase

5

38.12

1p ordinary

Purchase

13

38.12

1p ordinary

Purchase

28

38.14

1p ordinary

Purchase

34

38.12

1p ordinary

Purchase

40

38.12

1p ordinary

Purchase

47

38.14

1p ordinary

Purchase

60

38.12

1p ordinary

Purchase

82

38.12

1p ordinary

Purchase

141

38.12

1p ordinary

Purchase

145

38.14

1p ordinary

Purchase

184

38.12

1p ordinary

Purchase

250

38.12

1p ordinary

Purchase

325

38.12

1p ordinary

Purchase

1

38.14

1p ordinary

Purchase

3

38.12

1p ordinary

Purchase

4

38.14

1p ordinary

Purchase

6

38.12

1p ordinary

Purchase

10

38.12

1p ordinary

Purchase

15

38.14

1p ordinary

Purchase

23

38.12

1p ordinary

Purchase

25

38.14

1p ordinary

Purchase

26

38.14

1p ordinary

Purchase

27

38.1

1p ordinary

Purchase

32

38.12

1p ordinary

Purchase

35

38.1

1p ordinary

Purchase

35

38.1

1p ordinary

Purchase

36

38.12

1p ordinary

Purchase

37

38.12

1p ordinary

Purchase

38

38.12

1p ordinary

Purchase

42

38.12

1p ordinary

Purchase

43

38.12

1p ordinary

Purchase

47

38.12

1p ordinary

Purchase

48

38.12

1p ordinary

Purchase

50

38.1

1p ordinary

Purchase

50

38.12

1p ordinary

Purchase

51

38.12

1p ordinary

Purchase

53

38.12

1p ordinary

Purchase

53

38.12

1p ordinary

Purchase

54

38.12

1p ordinary

Purchase

55

38.1

1p ordinary

Purchase

62

38.14

1p ordinary

Purchase

63

38.12

1p ordinary

Purchase

70

38.12

1p ordinary

Purchase

71

38.12

1p ordinary

Purchase

75

38.12

1p ordinary

Purchase

83

38.12

1p ordinary

Purchase

90

38.12

1p ordinary

Purchase

91

38.14

1p ordinary

Purchase

97

38.12

1p ordinary

Purchase

97

38.12

1p ordinary

Purchase

99

38.12

1p ordinary

Purchase

100

38.12

1p ordinary

Purchase

103

38.12

1p ordinary

Purchase

107

38.12

1p ordinary

Purchase

107

38.12

1p ordinary

Purchase

107

38.12

1p ordinary

Purchase

108

38.12

1p ordinary

Purchase

109

38.12

1p ordinary

Purchase

110

38.12

1p ordinary

Purchase

113

38.12

1p ordinary

Purchase

115

38.12

1p ordinary

Purchase

120

38.12

1p ordinary

Purchase

125

38.12

1p ordinary

Purchase

125

38.12

1p ordinary

Purchase

126

38.12

1p ordinary

Purchase

126

38.12

1p ordinary

Purchase

126

38.12

1p ordinary

Purchase

130

38.12

1p ordinary

Purchase

132

38.12

1p ordinary

Purchase

135

38.12

1p ordinary

Purchase

135

38.14

1p ordinary

Purchase

137

38.14

1p ordinary

Purchase

138

38.12

1p ordinary

Purchase

140

38.12

1p ordinary

Purchase

140

38.14

1p ordinary

Purchase

142

38.12

1p ordinary

Purchase

142

38.12

1p ordinary

Purchase

143

38.14

1p ordinary

Purchase

148

38.12

1p ordinary

Purchase

150

38.12

1p ordinary

Purchase

151

38.14

1p ordinary

Purchase

153

38.12

1p ordinary

Purchase

154

38.12

1p ordinary

Purchase

154

38.12

1p ordinary

Purchase

155

38.12

1p ordinary

Purchase

157

38.12

1p ordinary

Purchase

158

38.12

1p ordinary

Purchase

163

38.12

1p ordinary

Purchase

165

38.14

1p ordinary

Purchase

167

38.12

1p ordinary

Purchase

167

38.12

1p ordinary

Purchase

167

38.12

1p ordinary

Purchase

167

38.12

1p ordinary

Purchase

169

38.12

1p ordinary

Purchase

169

38.14

1p ordinary

Purchase

169

38.14

1p ordinary

Purchase

171

38.12

1p ordinary

Purchase

179

38.14

1p ordinary

Purchase

188

38.14

1p ordinary

Purchase

190

38.12

1p ordinary

Purchase

191

38.12

1p ordinary

Purchase

200

38.14

1p ordinary

Purchase

201

38.12

1p ordinary

Purchase

204

38.12

1p ordinary

Purchase

204

38.14

1p ordinary

Purchase

209

38.12

1p ordinary

Purchase

216

38.12

1p ordinary

Purchase

218

38.12

1p ordinary

Purchase

223

38.12

1p ordinary

Purchase

224

38.12

1p ordinary

Purchase

248

38.12

1p ordinary

Purchase

264

38.12

1p ordinary

Purchase

267

38.12

1p ordinary

Purchase

277

38.12

1p ordinary

Purchase

282

38.12

1p ordinary

Purchase

291

38.12

1p ordinary

Purchase

310

38.1

1p ordinary

Purchase

375

38.1

1p ordinary

Purchase

400

38.14

1p ordinary

Purchase

462

38.1

1p ordinary

Purchase

496

38.1

1p ordinary

Purchase

232

38.14

1p ordinary

Purchase

3

38.12

1p ordinary

Purchase

4

38.12

1p ordinary

Purchase

9

38.12

1p ordinary

Purchase

27

38.12

1p ordinary

Purchase

71

38.12

1p ordinary

Purchase

93

38.12

1p ordinary

Purchase

102

38.12

1p ordinary

Purchase

133

38.12

1p ordinary

Purchase

144

38.12

1p ordinary

Purchase

207

38.12

1p ordinary

Purchase

232

38.12

1p ordinary

Purchase

237

38.12

1p ordinary

Purchase

241

38.12

1p ordinary

Purchase

312

38.12

1p ordinary

Purchase

313

38.12

1p ordinary

Purchase

359

38.12

1p ordinary

Purchase

526

38.12

1p ordinary

Purchase

602

38.12

1p ordinary

Purchase

636

38.12

1p ordinary

Purchase

643

38.12

1p ordinary

Purchase

650

38.12

1p ordinary

Purchase

652

38.12

1p ordinary

Purchase

657

38.12

1p ordinary

Purchase

693

38.12

1p ordinary

Purchase

744

38.12

1p ordinary

Purchase

1,465

38.12

1p ordinary

Purchase

1,599

38.12

1p ordinary

Purchase

2,015

38.12

1p ordinary

Purchase

2,183

38.12

1p ordinary

Purchase

143

38.12

1p ordinary

Purchase

232

38.12

1p ordinary

Purchase

146

38.12

1p ordinary

Purchase

1,784

38.12

1p ordinary

Sale

40

38.06

1p ordinary

Sale

58

38.04

1p ordinary

Sale

62

38.04

1p ordinary

Sale

71

38.06

1p ordinary

Sale

203

38.06

1p ordinary

Sale

327

38.06

1p ordinary

Sale

86

38.08

1p ordinary

Sale

117

38.08

1p ordinary

Sale

218

38.06

1p ordinary

Sale

232

38.14

1p ordinary

Sale

50

38.1

1p ordinary

Sale

117

38.1

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GBP

1p ordinary

CFD

Increasing a short position

92,000

38.10952

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

14/09/2023

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETGIGDCIDBDGXS
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.